This site is intended for U.S. Healthcare Professionals only.
Important Safety Information |
Prescribing Information
This site is intended for U.S. Healthcare Professionals only.
AVYCAZ is contraindicated in patients with known serious hypersensitivity to the components of AVYCAZ (ceftazidime and avibactam), avibactam-containing products, or other members of the cephalosporin class.
The most common adverse reactions in adult patients with cIAI (≥ 5% when used with metronidazole) were diarrhea (8%), nausea (7%), and vomiting (5%). The most common adverse reactions in adult patients with cUTI (3%) were diarrhea and nausea. The most common adverse reactions in adult patients with HABP/VABP (≥ 5%) were diarrhea (15%) and vomiting (6%).
The most common adverse reactions in pediatric patients with cIAI and cUTI (>3%) were vomiting, diarrhea, rash, and infusion site phlebitis.
Please also see full Prescribing Information.